• Renflexis, Biosimilar for Remicade to Treat Crohn’s and UC, Approved by FDA
  • The Five Most Aggravating Comments about Crohn’s Disease
  • Cannabinoid Combo Therapy Ended Teen’s Bowel Disease Symptoms, Study Reports
  • RedHill Wins Two More U.S. Patents on Gastrointestinal Therapy BEKINDA
  • Crohn’s Disease: ‘Beyond the Bathroom’ Series, Part One
  • Hospitalization Rates in Crohn’s Disease Suggest Patient Education Efforts Are Needed
  • Immuron Announces Positive Results of IMM-124E in Acute Colitis Research Program
  • Why I Don’t Mind Sharing About My Invisible Illness
  • Pfizer Awards Grant to UC Riverside Researchers for Discovery of IBD Therapeutic Target
  • Innovative Microbiome-based IBD Therapeutics to Be Developed Under New Partnership
  • The Emotional Side of Crohn’s
  • Vitality Biopharma Appoints Regulatory Advisor for Cannabis-Derived Prodrugs Program